Skip to main content
. 2021 Jul 31;10(15):3433. doi: 10.3390/jcm10153433

Figure 1.

Figure 1

Main renal biomarkers indicative of cardiorenal and renocardiac syndrome progression. NGAL: N-acetyl beta glucosaminidase. NAG: N-acetyl beta glucosaminidase. KIM 1: Kidney injury molecule. FABPs: Fat-ty acid-binding proteins; TIMP2 & IGFBP7: Tissue inhibitor of metalloproteinase 2 and insulin-like growth factor–binding protein 7.